Public filings / ORKA on Yahoo Finance (opens in a new tab)
ORKA: insider buying, 13F holders, analyst moves
Oruka Therapeutics Inc
A summary of public filings about Oruka Therapeutics Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold ORKA
Combined reported value $901.1M.
Holders among our 100 managers: 0 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RTW Investments | $298.7M | 2.55% | Added |
| Deep Track Capital | $183.3M | 2.70% | Trimmed |
| RA Capital | $148.0M | 1.29% | New |
| Viking Global Investors | $143.1M | 0.41% | Trimmed |
| Perceptive Advisors | $128.0M | 1.99% | Trimmed |
SEC Form 4
Recent insider trades in ORKA
| Filed (ET) | Insider | Type | Value | Filing |
|---|---|---|---|---|
| 2026-10-15 18:15 | Goncalves Joana Chief Medical Officer | Sale | $524K | SEC |
As of the last site build. The live lookup shows 12 months of Form 4 filings.
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.